nab-paclitaxel/carboplatin (nab-P/C) induction therapy in squamous (SCC) non-small cell lung cancer (NSCLC): Interim safety results from ABOUND.sqm-MedSci.cn

nab-paclitaxel/carboplatin (nab-P/C) induction therapy in squamous (SCC) non-small cell lung cancer (NSCLC): Interim safety results from ABOUND.sqm

Gridelli, C; McCleod, M; Morgensztern, D; Daniel, DB; Page, R; Wehler, T; Juan, O; Levy, B; Ardizzoni, A; Berry, T; Chen, T; Trunova, N; Jotte, R

ANNALS OF ONCOLOGY, 2017; 28 ( ):

科室
- - 订阅+
  - 更多科室
工具
服务